• Video
  • Shop
  • Culture
  • Family
  • Wellness
  • Food
  • Living
  • Style
  • Travel
  • News
  • Book Club
  • Newsletter
  • Privacy Policy
  • Your US State Privacy Rights
  • Children's Online Privacy Policy
  • Interest-Based Ads
  • Terms of Use
  • Do Not Sell My Info
  • Contact Us
  • © 2026 ABC News
  • Wellness

Women Snub HPV Vaccination

ByKRISTINA FIORE, MedPage Today Staff Writer
November 11, 2010, 8:11 PM

Nov. 13, 2010— -- PHILADELPHIA -- Less than a third of women who start out getting the human papillomavirus (HPV) vaccine wind up receiving all three necessary doses, researchers said here.

In a single-center study of almost 10,000 women eligible for vaccination -- those ages 9 to 26 -- only 30.78 percent of the women who started the HPV vaccine regimen actually completed the required three-dose series, Kathleen Tracy of the University of Maryland and colleagues reported at the American Association for Cancer Research Cancer Prevention meeting.

Read this story on www.medpagetoday.com.

Tracy told MedPage Today that the findings were generally consistent with a number of other studies based on electronic health record data -- and indicate that many young women are not protected against strains of HPV that could lead to cervical cancer.

Tracy said there were also patterns regarding age and race -- African-American women were more likely to initiate vaccination, but were less likely to follow through. The same was true for women over 18, she added.

"At 18, it's the first time you're making your own medical decisions, organizing your schedule, and making your own appointments," Tracy remarked. "This is the first time there's no parent involved in making those decisions and appointments."

The researchers looked at data from a University of Maryland electronic health record system, which included 9,658 teens and young women who were eligible for HPV vaccination between August 2006 and August 2010.

Among the 2,641 women who started on the HPV vaccine, 39.1 percent received a single dose, 30.1 percent got two doses, and 30.78 percent completed the recommended three-dose regimen.

"Any time you require a patient to get more than one dose, especially when it requires a clinic visit, you're setting up a barrier," Tracy said.

Age was a factor in adherence, as those 18 and older were less likely to take more than a single dose.And black women were less likely than whites to complete the series, the researchers found.

Up Next in Wellness—

FDA green-lights 1st new sunscreen ingredient in years

June 9, 2026

Doctor breaks down study showing GLP-1s may lower breast cancer risk

June 3, 2026

Identical twin doctors return to lead hometown hospital ER

June 3, 2026

Experimental pancreatic cancer drug offers new hope in major trial

June 1, 2026

Shop GMA Favorites

ABC will receive a commission for purchases made through these links.

Sponsored Content by Taboola

The latest lifestyle and entertainment news and inspiration for how to live your best life - all from Good Morning America.
  • Contests
  • Terms of Use
  • Privacy Policy
  • Do Not Sell My Info
  • Children’s Online Privacy Policy
  • Advertise with us
  • Your US State Privacy Rights
  • Interest-Based Ads
  • About Nielsen Measurement
  • Press
  • Feedback
  • Shop FAQs
  • ABC News
  • ABC
  • All Videos
  • All Topics
  • Sitemap

© 2026 ABC News
  • Privacy Policy— 
  • Your US State Privacy Rights— 
  • Children's Online Privacy Policy— 
  • Interest-Based Ads— 
  • Terms of Use— 
  • Do Not Sell My Info— 
  • Contact Us— 

© 2026 ABC News